Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade. Dr. Chowdhury began his presentation by emphasizing that muscle-invasive bladder cancer (MIBC) ...

Flo, a period and ovulation tracker app, advises: "It’s always a good idea to pee after sex, particularly for women. "Because ...

The latest findings, published in the medical journal BMJ, show a "substantial" link between certain anticholinergic drugs ...